These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 9437293)
21. [Profitability of hypolipidemic drug treatments]. Subías Lorén PJ; Ginés García C Med Clin (Barc); 1996 Jun; 107(1):37. PubMed ID: 8709673 [No Abstract] [Full Text] [Related]
22. Rapid increase in statins newly dispensed to Ontario seniors between 1994 and 2000. Levy AR; O'Brien BJ; McMullen E; May FW; Demers C; Marshall D; MacLeod S Can J Cardiol; 2003 May; 19(6):665-9. PubMed ID: 12772016 [TBL] [Abstract][Full Text] [Related]
23. Statins and strokes--reducing the risk. Jackson G Int J Clin Pract; 1999; 53(3):159. PubMed ID: 10665124 [No Abstract] [Full Text] [Related]
24. [Titles are power--the professors do not wish to discuss statins]. Ahnfeldt-Mollerup I; Heebøll-Nielsen NC Ugeskr Laeger; 1998 Sep; 160(39):5680-2. PubMed ID: 9771073 [No Abstract] [Full Text] [Related]
25. Use of statins. Cost effectiveness was studied in 4S study. Kjekshus J; Pedersen TR BMJ; 1997 Dec; 315(7122):1619-20. PubMed ID: 9437297 [No Abstract] [Full Text] [Related]
26. Epidemiology of dyslipidemia and economic burden on the healthcare system. Smith DG Am J Manag Care; 2007 Jun; 13 Suppl 3():S68-71. PubMed ID: 17596114 [TBL] [Abstract][Full Text] [Related]
27. [Also elderly patients with hyperlipidemia and coronary disease need lipid lowering agents]. Hellénius ML Lakartidningen; 2001 Sep; 98(39):4188-90. PubMed ID: 11680152 [No Abstract] [Full Text] [Related]
28. Why some patients respond poorly to statins and how this might be remedied. Thompson GR; O'Neill F; Seed M Eur Heart J; 2002 Feb; 23(3):200-6. PubMed ID: 11792134 [No Abstract] [Full Text] [Related]
29. [For prevention of cardiovascular diseases: statins in old age?]. MMW Fortschr Med; 2006 Sep; 148(38):16. PubMed ID: 17036955 [No Abstract] [Full Text] [Related]
30. Is fenofibrate a cost-saving treatment for middle-aged individuals with type II diabetes? An economic analysis of the FIELD Study. Carrington M; Stewart S Int J Cardiol; 2008 Jun; 127(1):51-6. PubMed ID: 17586072 [TBL] [Abstract][Full Text] [Related]
31. Predicting risk reduction of coronary disease in patients who are glucose intolerant: a comparison of treatment with fenofibrate and other lipid-modifying agents. Haffner SM; Ashraf T Manag Care Interface; 2000 Mar; 13(3):52-8. PubMed ID: 11066277 [TBL] [Abstract][Full Text] [Related]
32. National service framework for coronary heart disease. Target of lowering cholesterol by 30% needs to be justified. Cracknell P BMJ; 2000 Sep; 321(7261):634. PubMed ID: 11023319 [No Abstract] [Full Text] [Related]
33. [Secondary prevention after an acute myocardial infarct. Adrenergic beta-blockers, angiotensin-converting enzyme inhibitors and statins for everyone?]. Morais J Rev Port Cardiol; 2000 Jan; 19(1):99-105. PubMed ID: 10731795 [No Abstract] [Full Text] [Related]
34. Cholesterol reduction: what can we afford? Luepker RV Eur Heart J; 2001 May; 22(9):720-1. PubMed ID: 11350101 [No Abstract] [Full Text] [Related]
35. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia. Sorensen SV; Frick KD; Wade A; Simko R; Burge R Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159 [TBL] [Abstract][Full Text] [Related]
36. Eliminating out-of-pocket drug costs may improve outcomes after myocardial infarction--but at what cost to Medicare? Moran A; Goldman L Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):606-7. PubMed ID: 18695697 [TBL] [Abstract][Full Text] [Related]
37. [Statins becoming ever more versatile. Now also for prevention of atrial fibrillation and depression]. MMW Fortschr Med; 2003 Apr; 145(16):10. PubMed ID: 14606392 [No Abstract] [Full Text] [Related]